Brainsway Ltd. cash flow statement

In fiscal 2025, Brainsway Ltd.'s operations generated $17.5m of cash; it spent $0 on capital projects, leaving free cash flow of $17.5m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Brainsway Ltd.: cash flow statement, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	−3	−4	−7	−1	1	−10	1	10	17
Depreciation and amortisation	0	0	0	0	0	0	0	0	0
Stock-based pay	1	1	1	1	2	1	0	1	1
Capital spending	1	2	3	2	2	0	0	0	0
Free cash flow	−4	−6	−11	−4	−1	−10	1	10	17
Free cash flow after stock pay	−5	−6	−12	−5	−3	−11	1	9	16

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BWAY vs IRIX BWAY vs SENS APYX vs BWAY

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Brainsway Ltd.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Brainsway Ltd.